Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2012
07/12/2012US20120178712 Phytochemical compositions including sesamin for anti-inflammatory, anti-cytokine storm, and other uses
07/12/2012US20120178709 CRYSTALLINE PHASES OF 5,6-DFICHLORO-2-(ISOPROPYLAMINO)-1-ß-L-RIBOFURANOSYL)-1H-BENZIMIDAZOLE
07/12/2012US20120178678 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
07/12/2012US20120178674 Mixture of non-digestible oligosaccharides for stimulating the immune system
07/12/2012US20120178671 Inhibition of nfk-b mediated virus replication with specific oligosaccharides
07/12/2012US20120178669 Protease inhibitors, compositions and methods of use
07/12/2012US20120178668 Proteinaceous compounds and uses therefor
07/12/2012US20120178667 Methods for treating septic shock
07/12/2012US20120178629 Apparatus and methods for preparing an emulsion
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120178157 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120177762 Inhibition of exoproteins using bacteria of the lactobacillus genus
07/12/2012US20120177760 Cosmetic or dermotological composition containing hydrolyzates made of plant extracts
07/12/2012US20120177754 Inhibitor of inflammatory conditions
07/12/2012US20120177752 Nutritional compositions including beta-hydroxy-beta-methylbutyrate
07/12/2012US20120177741 Positively-charged poly (d,l-lactide-co-glycolide) nanoparticles and fabrication methods of the same
07/12/2012US20120177725 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
07/12/2012US20120177721 Formulation
07/12/2012US20120177720 Multi-layer wound dressings
07/12/2012US20120177719 Medical device intended to come into contact with a patient's tissue and related manufacturing method
07/12/2012US20120177716 Methods for Making Controlled Delivery Devices Having Zero Order Kinetics
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177702 Solid Forms for Tissue Repair
07/12/2012US20120177701 Compositions comprising immunostimulatory nucleic acids and related methods
07/12/2012US20120177699 Preparation Method of Drug Loaded Emulsion
07/12/2012US20120177696 Diffusion-controlled dosage form and method of fabrication including three dimensional printing
07/12/2012US20120177694 Methods and Apparatus for Manufacturing Plasma Based Plastics and Bioplastics Produced Therefrom
07/12/2012US20120177692 Delivery systems for solubilising water-insoluble pharmaceutical active ingredients
07/12/2012US20120177691 Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit
07/12/2012US20120177687 Gene expressing a bifidobacterium surface-presented fusion protein
07/12/2012US20120177686 Vaccine for the prevention of acute lymphoblastic leukemia
07/12/2012US20120177685 Peptide vaccines against group a streptococci
07/12/2012US20120177684 Papillomavirus vaccine compositions
07/12/2012US20120177683 Methods for preparing vesicles and formulations produced therefrom
07/12/2012US20120177681 Formulation of immunopotentiators
07/12/2012US20120177680 Polypeptides and methods for the specific detection of antibodies in patients with a borrelia infection
07/12/2012US20120177677 Antigen specific multi epitope-based anti-infective vaccines
07/12/2012US20120177676 Alphabodies for hiv entry inhibition
07/12/2012US20120177675 Chimaeric Protein
07/12/2012US20120177663 Therapeutic Monoclonal Antibodies that Neutralize Botulinum Neurotoxins
07/12/2012US20120177657 Fusion proteins comprising cd4 minimal modules and methods of use thereof
07/12/2012US20120177650 Therapy for enteric infections
07/12/2012US20120177637 Method for selecting a single cell expressing a heterogeneous combination of antibodies
07/12/2012US20120177620 Probiotic, Lactic Acid-Producing Bacteria
07/12/2012US20120177610 Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
07/12/2012US20120177609 Method for using liberated dormant bacteriophase and environmental stress to reduce infectious bacteria
07/12/2012US20120177608 Pseudomonas aeruginosa bacteriophage(s) and uses thereof
07/12/2012US20120177601 Treatment of hepatitis c virus infections
07/12/2012US20120177598 Compositions and Methods for Immunomodulation in an Organism
07/12/2012US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
07/12/2012CA2826086A1 Process for preparation of caspofungin acetate and intermediates
07/12/2012CA2823969A1 2,4-diamino-6,7-dihydro-5h-pyrrolo[2,3]pyrimidine derivatives as fak/pyk2 inhibitors
07/12/2012CA2823908A1 Method for selecting patient to be given drug for treating septicemia
07/12/2012CA2823747A1 Liposome formulation suitable for treating or preventing tuberculosis
07/11/2012EP2474558A1 New antibiotic containing simulacrum antibody, preparation method and application thereof
07/11/2012EP2474547A2 Process for the Synthesis of Moxifloxacin Hydrochloride
07/11/2012EP2474323A2 Imidazoquinolines and pyrimidine derivatives as potent modulators of vegf-driven angiogenic processes
07/11/2012EP2474322A1 Products for prophylaxis and/or treatment of viral diseases and method of making and using same
07/11/2012EP2473516A1 Antibiotic compounds
07/11/2012EP2473503A1 Bis-benzimidazole derivatives
07/11/2012EP2473493A1 Methods of treating poxviral infections
07/11/2012EP2473482A1 Methods of treating orthomyxoviral infections
07/11/2012EP2473480A1 Novel antibacterial hydroxyphenyl compound
07/11/2012EP2473177A2 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same
07/11/2012EP2473159A2 A composition for delaying cellular senescence
07/11/2012EP2473057A2 Picrorhiza kurroa extract for prevention, elimination and treatment of infection diseases
07/11/2012EP2473056A1 Chemical compounds
07/11/2012EP2473046A1 Iminosugars and methods of treating filoviral diseases
07/11/2012EP2473042A1 Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds
07/11/2012EP2313408B1 Diketopiperidine derivatives as hiv attachment inhibitors
07/11/2012EP2187913B1 Ac-RFMWMR-NH2 for use in the treatment of Mycobacterium tuberculosis related diseases
07/11/2012EP1971588B1 Tiglien-3-one derivatives
07/11/2012EP1590360B1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
07/11/2012EP1472224B1 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
07/11/2012EP1259547B1 High potency recombinant antibodies and method for producing them
07/11/2012EP1169456B1 Recombinant production of Clostridium difficile Toxin A or Toxin B
07/11/2012CN1899593B Powder for treating common cold and its preparing method
07/11/2012CN102575252A Polynucleotides for multivalent RNA interference, compositions and methods of use thereof
07/11/2012CN102575250A Treatment and diagnosis of immune disorders
07/11/2012CN102575231A Process for production of cytokine-induced killer cells
07/11/2012CN102574892A Antibiotic compounds
07/11/2012CN102574854A Macrocyclic integrase inhibitors
07/11/2012CN102574844A Maleic acid salt and crystal thereof
07/11/2012CN102574840A R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
07/11/2012CN102573903A Composition for treating HBV infection
07/11/2012CN102573900A New vaccine formulations comprising saponin-containing adjuvants
07/11/2012CN102573897A Nebulizable tuberculosis vaccine for transnasal administration comprising paramyxovirus vector
07/11/2012CN102573891A Polymer particles and uses thereof
07/11/2012CN102573882A Methods of treating bacterial infections using oritavancin
07/11/2012CN102573870A Composition for the prevention and treatment of influenza virus infection and composition for suppressing neuraminidase activity comprising turmeric extract
07/11/2012CN102573868A Therapeutic uses for plants of the capsicum genus
07/11/2012CN102573866A Anti-influenza virus agent
07/11/2012CN102573840A Pharmaceutical compositions
07/11/2012CN102573829A Composition comprising S-allyl-L-cysteine as active ingredient for preventing or treating gastrointestinal disorders
07/11/2012CN102573815A Treatment and prevention of HIV infection
07/11/2012CN102573770A Isopropyl methyl phenol-containing liquid composition for oral cavity
07/11/2012CN102559828A Method for preparing astragaloside IV by converting total saponins of astragalus by microorganisms
07/11/2012CN102559823A Frog skin extract and extraction method thereof
07/11/2012CN102559816A Preparation method of antibacterial lipopeptide and application thereof to veterinary medicine
1 ... 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 ... 1798